Strainsforpains, Inc. Enters into a Letter of Intent to Acquire Cannasphere Biotech, LLC

2y
3m read
Summary

Cannasphere Biotech is also working to launch the first patented liposomal liquid-filled gummy. “We are excited about the possibility of the acquisition by Strainsforpains. NEW YORK, NY / ACCESSWIRE / August 11, 2021 / Strainsforpains, Inc. (OTC Markets:EBYH), a New York-based purveyor of enterprise-class technology solutions for the cannabis industry, announces that it has signed a letter of intent to acquire Cannasphere Biotech, LLC, an Arizona-based developer and manufacturer of water-soluble, nanoliposomal cannabinoid products serving business clients in the cannabis industry. More information about the potential factors that could affect the business and financial results is and will be included in Strainsforpains, Inc.’s filings with the Securities and Exchange Commission. Among the variety of products featured in Cannasphere Biotech’s commercial catalogue are broad-spectrum CBD powders, liquids, and tablets for white-label clients, and isolated cannabinoids customized to order for manufacturers. Although Strainsforpains, Inc. believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, Strainsforpains, Inc. is unable to give any assurance that its expectations will be attained.

Article Preview

NEW YORK, NY / ACCESSWIRE / August 11, 2021 / Strainsforpains, Inc. (OTC Markets:EBYH), a New York-based purveyor of enterprise-class technology solutions for the cannabis industry, announces that it has signed a letter of intent to acquire Cannasphere Biotech, LLC, an Arizona-based developer and manufacturer of water-soluble, nanoliposomal cannabinoid products serving business clients in the cannabis industry. Poised to emerge as a global player in the rapidly-growing cannabis and CBD markets, Strainsforpains is well-positioned with its database of cannabis cultivars and strain varietals to capitalize...

Read the full article @ Cannabis Law Report